Lagoda Investment discloses 14.0% VolitionRX (VNRX) stake in amended Schedule 13G

Rhea-AI Filing Summary

Lagoda Investment Management, L.P. filed an amended Schedule 13G reporting significant ownership in VolitionRX Ltd common stock. As of June 30, 2026, accounts managed by Lagoda held 1,455,950 shares of common stock and warrants to purchase 171,055 shares at an exercise price of $0.60 per share. Based on 12,044,339 shares outstanding as of June 26, 2026, Lagoda is deemed to beneficially own 1,627,005 shares, representing 14.0% of VolitionRX’s common stock, with sole voting and dispositive power over these securities.

Key Figures

Beneficially owned shares: 1,627,005 shares Ownership percentage: 14.0% Common shares held: 1,455,950 shares +3 more

6 metrics

Beneficially owned shares 1,627,005 shares Common stock beneficially owned by Lagoda Investment Management, L.P.

Ownership percentage 14.0% Portion of VolitionRX common stock beneficially owned based on shares outstanding

Common shares held 1,455,950 shares Shares of VolitionRX common stock held by Lagoda-managed accounts as of June 30, 2026

Warrants held 171,055 warrants Warrants to purchase VolitionRX common stock held by Lagoda-managed accounts

Warrant exercise price $0.60 per share Exercise price of warrants to purchase VolitionRX common stock

Shares outstanding 12,044,339 shares VolitionRX common shares issued and outstanding as of June 26, 2026

Key Terms

beneficially owns, Sole Voting Power, Sole Dispositive Power, warrants to purchase, +1 more

5 terms

beneficially owns financial

"the Reporting Person beneficially owns 1,627,005 shares of Common Stock"

Beneficially owns means a person or entity enjoys the economic benefits and control of a security even if the legal title or registration is held in another name. Think of it like having the keys and profits from a car that is registered to a friend: you use it, benefit from it, and make decisions about it even though the official paperwork lists someone else. For investors, this matters because it reveals who truly controls shares, affects voting power, potential conflicts of interest, and regulatory disclosure obligations.

Sole Voting Power financial

"Sole Voting Power 1,627,005.00 6 | Shared Voting Power 0.00"

Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.

Sole Dispositive Power financial

"Sole Dispositive Power 1,627,005.00 8 | Shared Dispositive Power 0.00"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

warrants to purchase financial

"warrants to purchase 171,055 shares of Common Stock at an exercise price"

Percent of class financial

"Percent of class: 14.0 %"

Percent of class is the portion of a specific category of securities—such as a company’s common shares, preferred shares, or a bond series—that takes part in or approves a corporate action (vote, consent, tender, etc.). Investors watch this number because it reveals how much support or opposition exists within that particular shareholder group; like counting how many members of a club back a proposal, it can determine whether a plan passes or how influence is distributed.

FAQ

What percentage of VolitionRX Ltd (VNRX) does Lagoda Investment Management own?

Lagoda Investment Management is reported to beneficially own 14.0% of VolitionRX Ltd’s common stock, representing 1,627,005 shares based on 12,044,339 shares outstanding as of June 26, 2026.

How many VolitionRX Ltd (VNRX) shares and warrants does Lagoda hold?

As of June 30, 2026, Lagoda-managed accounts held 1,455,950 common shares and warrants for 171,055 shares of VolitionRX Ltd common stock, all included in the reported 1,627,005 beneficially owned shares.

What is the exercise price of Lagoda’s VolitionRX Ltd (VNRX) warrants?

Lagoda’s accounts hold warrants to purchase 171,055 shares of VolitionRX Ltd common stock at an exercise price of $0.60 per share, which are included in the reported beneficial ownership.

On what share count is Lagoda’s 14.0% VolitionRX (VNRX) stake based?

The 14.0% beneficial ownership is calculated using 12,044,339 shares outstanding of VolitionRX Ltd common stock as of June 26, 2026, as referenced in a registration statement.

Who controls voting and dispositive power over Lagoda’s VolitionRX Ltd (VNRX) holdings?

Lagoda Investment Management, L.P. has sole voting power and sole dispositive power over 1,627,005 shares of VolitionRX Ltd common stock held in its managed accounts.

Who ultimately oversees Lagoda’s VolitionRX Ltd (VNRX) investment?

Lagoda Investment Management, L.P.’s general partner is Lagoda Investment Management, LLC, whose sole member Fatima Dickey holds the voting and dispositive power over the securities beneficially owned by the reporting person.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/14/2026 - 04:22 PM Accepted by SEC EDGAR 08/14/2026 - 04:15 PM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 6)

VolitionRX Ltd

(Name of Issuer)

Common Stock, par value $0.001 per share

(Title of Class of Securities)

928661206

(CUSIP Number)

06/30/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 928661206

1

Names of Reporting Persons

Lagoda Investment Management, L.P.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 1,627,005.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 1,627,005.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

1,627,005.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

14.0 %

12

Type of Reporting Person (See Instructions)

IA

Comment for Type of Reporting Person: See Item 2 for additional information.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: VolitionRX Ltd
(b)	Address of issuer's principal executive offices: 1489 West Warm Springs Road Suite 110 Henderson NV 89014.
Item 2.
(a)	Name of person filing: This report on Schedule 13G/A (as amended, this "Schedule 13G") is being filed by Lagoda Investment Management, L.P. (the "Reporting Person"). The Reporting Person serves as the investment manager to certain managed accounts (the "Accounts") and possesses the sole power to vote and the sole power to direct the disposition of all securities of the Issuer held by the Accounts. The general partner of the Reporting Person is Lagoda Investment Management, LLC, a Delaware limited liability company (the "General Partner"). Fatima Dickey, as the sole member of the General Partner, possesses the voting and dispositive power with respect to all securities beneficially owned by the Reporting Person. As of June 30, 2026, the Accounts held (i) 1,455,950 shares of common stock, par value $0.001 per share (the "Common Stock"), and (ii) warrants to purchase 171,055 shares of Common Stock at an exercise price of $0.60 per share. Ownership percentages are based on 12,044,339 Shares issued and outstanding as of June 26, 2026, as reported by the Issuer in its Registration Statement on Form S-3, filed with the Securities and Exchange Commission on July 10, 2026. As a result of the foregoing, for purposes of Reg. Section 240.13d-3, the Reporting Person beneficially owns 1,627,005 shares of Common Stock, including shares of Common Stock underlying warrants held in the aggregate by the Accounts.
(b)	Address or principal business office or, if none, residence: The address for the Reporting Person is 3 Columbus Circle, New York, NY 10019.
(c)	Citizenship: The Reporting Person is organized under the laws of the State of Delaware.
(d)	Title of class of securities: Common Stock, par value $0.001 per share
(e)	CUSIP No.: 928661206
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 1,627,005.00
(b)	Percent of class: 14.0 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 1,627,005.00
	(ii) Shared power to vote or to direct the vote: 0.00
	(iii) Sole power to dispose or to direct the disposition of: 1,627,005.00
	(iv) Shared power to dispose or to direct the disposition of: 0.00
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Lagoda Investment Management, L.P.

Signature:	/s/ Jason A. Ozone
Name/Title:	Jason A. Ozone / Chief Financial Officer & Chief Compliance Officer
Date:	08/14/2026